MedTrace Logo

A Study on Cytomegalovirus (CMV) Infection Outcomes Among Solid Organ Transplant (SOT) Participants in Europe and Canada

NCT05576805 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2024-04-25

No results posted yet for this study

Summary

The main aim of the study is to assess the clinical outcomes of current CMV management across different regions of the world (Europe \[EU\] and Canada \[CAN\]). Data will be collected retrospectively from medical charts.

No study medicines will be provided to participants in this study.

Conditions

  • Cytomegalovirus (CMV)

Sponsors & Collaborators

Principal Investigators

  • Study Director · Takeda

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-19
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Austria
  • Belgium
  • Canada
  • Greece
  • Israel
  • Italy
  • Netherlands
  • Poland
  • Sweden

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05576805 on ClinicalTrials.gov